Leticia Calahorra Melero

Dr. Leticia Calahorra Melero

Grupo de Neuroinmuno-Reparación. Hospital Nacional de Paraplejicos de Toledo. Spain
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2022 in Biomedicines
Verified
Journal Article
Open access
PDF file
Leticia Calahorra MeleroLeticia Calahorra Melero
Leticia Calahorra Melero
CCCelia Camacho-Toledano
Celia Camacho-Toledano
Mari Paz Serrano-RegalMari Paz Serrano-Regal
Mari Paz Serrano-Regal
MOMaría Cristina Ortega
María Cristina Ortega
Diego Clemente LópezDiego Clemente López
Diego Clemente López
Multiple sclerosis (MS) is a chronic, autoimmune, and neurodegenerative disease of the central nervous system (CNS) that affects myelin. The etiology of MS is unclear, although a variety of environmental and genetic factors are thought to increase the risk of developing the disease. Historically, T cells were considered to be the orchestrators of MS pathogenesis, but evidence has since accumulated implicating B lymphocytes and innate immune cells in the inflammation, demyelination, and axonal damage associated with MS disease progression. However, more recently the importance of the protective role of immunoregulatory cells in MS has become increasingly evident, such as that of myeloid-derived suppressor cells (MDSCs), regulatory T (Treg) and B (Breg) cells, or CD56bright natural killer cells. In this review, we will focus on how peripheral regulatory cells implicated in innate and adaptive immune responses are involved in the physiopathology of MS. Moreover, we will discuss how these cells are thought to act and contribute to MS histopathology, also addressing their promising role as promoters of successful remyelination within the CNS. Finally, we will analyze how understanding these protective mechanisms may be crucial in the search for potential therapies for MS.

1 May 2017 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Open access
ESElizabeth Sarmiento
Elizabeth Sarmiento
MJMaria Jaramillo
Maria Jaramillo
Leticia Calahorra MeleroLeticia Calahorra Melero
Leticia Calahorra Melero
JFJuan Fernandez-Yañez
Juan Fernandez-Yañez
MGMiguel Gomez-Sanchez
Miguel Gomez-Sanchez
JCJavier Carbone
Javier Carbone
New biomarkers are necessary to improve detection of the risk of infection in heart transplantation. We performed a multicenter study to evaluate humoral immunity profiles that could better enable us to identify heart recipients at risk of severe infections. We prospectively analyzed 170 adult heart recipients at 8 centers in Spain. Study points were before transplantation and 7 and 30 days after transplantation. Immune parameters included IgG, IgM, IgA and complement factors C3 and C4, and titers of specific antibody to pneumococcal polysaccharide antigens (anti-PPS) and to cytomegalovirus (CMV). To evaluate potential immunologic mechanisms leading to IgG hypogammaglobulinemia, before heart transplantation we assessed serum B-cell activating factor (BAFF) levels using enzyme-linked immunoassay. The clinical follow-up period lasted 6 months. Clinical outcome was need for intravenous anti-microbials for therapy of infection. During follow-up, 53 patients (31.2%) developed at least 1 severe infection. We confirmed that IgG hypogammaglobulinemia at Day 7 (defined as IgG <600 mg/dl) is a risk factor for infection in general, bacterial infections in particular, and CMV disease. At Day 7 after transplantation, the combination of IgG <600 mg/dl + C3 <80 mg/dl was more strongly associated with the outcome (adjusted odds ratio 7.40; 95% confidence interval 1.48 to 37.03; p = 0.014). We found that quantification of anti-CMV antibody titers and lower anti-PPS antibody concentrations were independent predictors of CMV disease and bacterial infections, respectively. Higher pre-transplant BAFF levels were a risk factor of acute cellular rejection. Early immunologic monitoring of humoral immunity profiles proved useful for the identification of heart recipients who are at risk of severe infection.

17 September 2016 in Transplant Infectious Disease
Verified
Journal Article
Closed access
PDF file
ESElizabeth Sarmiento
Elizabeth Sarmiento
PDPablo Diez
Pablo Diez
MAMauricio Arraya
Mauricio Arraya
MJMaria Jaramillo
Maria Jaramillo
Leticia Calahorra MeleroLeticia Calahorra Melero
Leticia Calahorra Melero
JCJavier Carbone
Javier Carbone

1 August 2018 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Closed access
ESElizabeth Sarmiento
Elizabeth Sarmiento
JCJose Cifrian
Jose Cifrian
Leticia Calahorra MeleroLeticia Calahorra Melero
Leticia Calahorra Melero
CBCarles Bravo
Carles Bravo
SLSonia Lopez
Sonia Lopez
JCJavier Carbone
Javier Carbone

20 May 2013 in Transplant International
Verified
Journal Article
Open access
PDF file
NLNallibe Lanio
Nallibe Lanio
ESElizabeth Sarmiento
Elizabeth Sarmiento
AGAntonio Gallego
Antonio Gallego
Leticia Calahorra MeleroLeticia Calahorra Melero
Leticia Calahorra Melero
MJMaría Jaramillo
María Jaramillo
JCJavier Carbone
Javier Carbone
Rejection and infection are relevant causes of mortality in heart recipients. We evaluated the kinetics of the maturation status of B lymphocytes and its relationship with acute cellular rejection and severe infection in heart recipients. We analyzed B‐cell subsets using 4‐color flow cytometry in a prospective follow‐up study of 46 heart recipients. Lymphocyte subsets were evaluated at specific times before and up to 1 year after transplantation. Higher percentages of pretransplant class‐switched memory B cells (CD19+CD27+IgM‐IgD‐ >14%) were associated with a 74% decrease in the risk of severe infection [Cox regression relative hazard (RH) 0.26, 95% confidence interval (CI), 0.07–0.86; P = 0.027]. Patients with higher percentages of naïve B cells at day 7 after transplantation (CD19+CD27‐IgM+IgD+ >58%) had a 91% decrease in the risk of developing acute cellular rejection (RH 0.09; 95% CI, 0.01–0.80; P = 0.02). Patients with infections showed a strong negative correlation between baseline serum B‐cell–activating factor (BAFF) concentration and absolute counts of memory class‐switched B cells (R = −0.81, P = 0.01). The evaluation of the immunophenotypic maturation status of B lymphocytes could prove to be a useful marker for identifying patients at risk of developing rejection or infection after heart transplantation.

16 October 2020 in Transplant Infectious Disease
Verified
Journal Article
Closed access
PDF file
ESElizabeth Sarmiento
Elizabeth Sarmiento
MJMaricela Jimenez
Maricela Jimenez
MNMarisa di Natale
Marisa di Natale
MRMarisa Rodriguez‐Ferrero
Marisa Rodriguez‐Ferrero
FAFernando Anaya
Fernando Anaya
JCJavier Carbone
Javier Carbone